glp-1 news past 2 days Timeline of critical milestones in the development and use of Study shows liraglutide results in

The synergistic combination of glucagon-like peptide-1 (GLP-1) receptor agonists with other anti-diabetic agents presents a promising approach for glycemic control in type 2 diabetes

We selected all histomorphometric parameters in five random visual fields per specimen, and measured four sections per animal in each group

While potential long-term benefits to health outcomes from GLP-1s are welcomed, the short-term cost impact to health insurers must be considered

The lack of pharmacological overlap between tirzepatide and lupus biologics is actually one of the strongest arguments for its safety in this population

(a) Stress load

Pericyte deficiency intensifies amyloid-beta (A) and tau pathology and accelerates neuronal loss in the absence of A-precursor protein, leading to cognitive decline [45]